| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |